Laboratory Investigation
United States and Canadian Academy of Pathology The United States and Canadian Academy of Pathology
LWW Lippincott Williams and Wilkins
publishes Laboratory Investigation
--
                                      View Future Titles
Through Mar 2001
       Archives
Aug 1965 - Feb 2001
       Search Articles
Aug 1965 - Feb 2001
       Browse by Subject
Aug 1965 - Feb 2001
                      
Instructions to authors

Subscriptions

About the journal
   
  Comparative Genomic Hybridization Analysis of Myoepithelial Carcinoma of the Breast
Editorial board

Email alerts

'Net Tips

Help

Feedback

Guestbook








  Chris Jones, Maria P. Foschini, Ranbir Chaggar, Yong-J Lu, Dagan Wells, Janet M. Shipley, Vincenzo Eusebi, and Sunil R. Lakhani
   
  Departments of Histopathology (CJ, SRL), Royal Free and University College Medical School, University College, London; Sezione di Anatomia (MPF, VE), Istologia e Citologia Patologica "M. Malpighi," Università di Bologna; The Ludwig Institute for Cancer Research (RC), UCL Branch; Section of Cell and Experimental Pathology (Y-JL, JMS), The Institute for Cancer Research, Surrey; and Department of Obstetrics and Gynaecology (DW), University College London, United Kingdom
   
 

SUMMARY:

Although there seems to be a common stem cell for the two epithelial cell types in the breast, the vast majority of breast cancers exhibit a luminal phenotype. Pure myoepithelial carcinomas are rare. We report our findings of genetic alterations in these tumors. We have analyzed 10 cases of pure myoepithelial cell carcinomas using laser capture microdissection and comparative genomic hybridization. The mean number of changes was 2.1 (range 0-4), compared with a mean of 8.6 (range 3.6-13.8) in unselected ductal carcinomas. Common alterations included loss at 16q (3/10 cases), 17p (3/10), 11q (2/10), and 16p (2/10), regions also commonly deleted in ductal carcinomas. The single case in which both pure myoepithelial carcinoma and invasive ductal carcinoma was present showed 2 alterations in the myoepithelial tumor (losses at 17p and 17q), whereas the invasive ductal component showed 15 alterations (5 gains and 9 losses), including loss at 17p. The sharing of 17p loss in myoepithelial and ductal carcinoma is consistent with a common stem cell model in the breast. The relatively few genetic alterations in otherwise aggressive neoplasms suggests that myoepithelial tumors may be a good model for the delineation of genes important in breast tumorigenesis.